Molecular biology of rhabdomyosarcoma

Clinical and Translational Oncology

Volumn 9, Issue 7, 2007, Pages 415-419

  Gallego Melcon S ^a   Sanchez de Toledo Codina J ^a  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

Author keywords

Genetic abnormalities; Minimal disseminated disease; Rhabdomyosarcoma

Indexed keywords

CHOLINERGIC RECEPTOR; MESSENGER RNA; MYOD1 PROTEIN; MYOGENIN; TRANSCRIPTION FACTOR FKHR; TRANSCRIPTION FACTOR PAX3; TRANSCRIPTION FACTOR PAX7; FORKHEAD TRANSCRIPTION FACTOR; FOXO1A PROTEIN, HUMAN; PAIRED BOX TRANSCRIPTION FACTOR; PAX3 PROTEIN, HUMAN; UNCLASSIFIED DRUG;

ARTICLE; BONE MARROW METASTASIS; CHROMOSOME 1; CHROMOSOME 11; CHROMOSOME 13; CHROMOSOME TRANSLOCATION 1; CHROMOSOME TRANSLOCATION 13; CHROMOSOME TRANSLOCATION 2; DNA MICROARRAY; EMBRYONAL RHABDOMYOSARCOMA; GENE AMPLIFICATION; GENE DISRUPTION; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE INACTIVATION; GENETIC DISORDER; HETEROZYGOSITY LOSS; HISTOPATHOLOGY; HUMAN; MINIMAL RESIDUAL DISEASE; MOLECULAR BIOLOGY; PROGNOSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RHABDOMYOSARCOMA; RISK FACTOR; SERIAL ANALYSIS OF GENE EXPRESSION; TUMOR CLASSIFICATION; BIOLOGICAL MODEL; GENE TRANSLOCATION; GENETICS; METABOLISM; REVIEW; SIGNAL TRANSDUCTION;

FORKHEAD TRANSCRIPTION FACTORS; HUMANS; MODELS, BIOLOGICAL; PAIRED BOX TRANSCRIPTION FACTORS; RHABDOMYOSARCOMA; RHABDOMYOSARCOMA, ALVEOLAR; RHABDOMYOSARCOMA, EMBRYONAL; SIGNAL TRANSDUCTION; TRANSLOCATION, GENETIC;

EID: 35748940315     PISSN: 1699048X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12094-007-0079-3     Document Type: Article

References (38)

1. IARC (1998) International incidence of childhood cancer, 1998 (IICC-2), Vol. II. IARC Scientific Publication No. 144
2. Meyer WH, Spunt SL (2004) Soft tissue sarcomas of childhood. Cancer Treat Rev 30:269-280
3. Pappo AS, Shapiro DN, Crist WM, Maurer HM (1995) Biology and therapy of pediatric rhabdomyosarcoma. J Clin Oncol 13:2123-2139
4. Crist WM, Anderson JR, Meza JL et al (2001) Intergroup rhabdomyosarcoma study-IV: Results for patients with nonmetastatic disease. J Clin Oncol 19:3091-3102
5. Raney RB, Anderson JR, Barr FG et al (2001) Rhabdomyosarcoma and Undifferentiated Sarcoma in the First Two Decades of Life: A Selective Review of Intergroup Rhabdomyosarcoma Study Group Experience and Rationale for Intergroup Rhabdomyosarcoma Study V. Am J Pediatr Hematol Oncol 23:215-220
6. Newton WA Jr, Gehan EA, Webber BL et al (1995) Classification of rhabdomyosarcomas and related sarcomas. Pathologic aspects and proposal for a new classification - an Intergroup Rhabdomyosarcoma Study. Cancer 76:1073-1085
7. Scrable H, Witte D, Shimada H et al (1989) Molecular differential pathology of rhabdomyosarcoma. Genes Chromosomes Cancer 1:23-35
8. Loh EWJ, Scrable HJ, Livanos E et al. Human chromosome 11 contains two different growth suppresser genes for embryonal rhabdomyosarcoma. Proc Natl Acad Sci U S A 89:1755-1759
9. Bridge JA, Liu J, Weibolt V et al (2000) Novel genomic imbalances in embryonal rhabdomyosarcoma revealed by comparative genomic hybridization: An Intergroup Rhabdomyosarcoma Study. Genes Chromosome Cancer 27: 337-344
10. Barr FG (1997) Molecular genetics and pathogenesis of rhabdomyosarcoma. J Pediatr Hematol Oncol 19:483-491
11. Barr FG (2001) Gene fusions involving PAX and FOX family members in alveolar rhabdomyosarcoma. Oncogene 20:5736-5746
12. Galili N, Davis RJ, Fredericks WJ et al (1993) Fusion of a fork head domain gene to PAX 3 in the solid tumour alveolar rhabdomyosarcoma. Nat Genet 5:230-235
13. Davis RJ, D'Cruz CM, Lowell MA et al (1994) Fusion of PAX7 to the FKHR by the variant t(1;13) (p36;q14)translocation in alveolar rhabdomyosarcomas. Cancer Res 54:2869-2872
14. Bennicelli JL, Fredericks WJ, Wilson RB et al (1995) Wild-type PAX3 protein and the PAX3-FKHR fusion protein of alveolar rhabdomyosarcoma contain potent, structurally distinct transcriptional activation domains. Oncogene 11: 119-130
15. Ludolph DC, Konieczny SF (1995) Transcription factor families: Muscling in on the myogenic program. FASEB J 9:1595-1604
16. Scheidler S, Fredericks WJ, Rauscher FJ III (1996) The hybrid PAX3-FKHR fusion protein of alveolar rhabdomyosarcoma transforms fibroblasts in culture. Proc Natl Acad Sci U S A 93:9805-9809
17. Bernasconi M, Remppis A, Fredericks WJ et al (1996) Induction of apoptosis in rhabdomyosarcoma cells through down-regulation of PAX proteins. Proc Natl Acad Sci U S A 93: 13164-13169
18. Anderson J, Gordon A, Pritchard-Jones K et al (1999) Genes, chromosomes and rhabdomyosarcoma. Genes Chromosome Cancer 26:275-285
19. Sorensen PHB, Lynch JC, Qualman SJ et al (2002) PAX3-FKHR and PAX7-FKHR gene fusions are prognostic indicators in alveolar rhabdomyosarcoma: A report from the Children's Oncology Group. J Clin Oncol 20:2672-2679
20. Driman D, Thorner PS, Greenberg ML et al (1994) MYCN gene amplification in rhabdomyosarcoma. Cancer 15:2231-2237
21. Forus A, Florenes VA, Maelandsmo GM et al (1993) Mapping of amplification units in the q13-14 region of chromosome 12 in human sarcomas: Some amplicons do not include MDM2. Cell Growth Differ 4:1065-1070
22. Visser M, Sijmons C, Bras J et al (1997) Allelotype of pediatric rhabdomyosarcoma. Oncogene 15:1309-1314
23. Skubitz KM, Skubitz AP (2004) Characterization of sarcomas by means of gene expression. J Lab Clin Med 144:78-91
24. Baird K, Davis S, Antonescu CR et al (2005) Gene expression profiling of human sarcomas: Insights into sarcoma biology. Cancer Res 65:9226-9235
25. West RB, van de Rijn M (2006) The role of microarray technologies in the study of soft tissue tumours. Histopathology 48:22-31
26. Khan J, Wie JS, Ringner M et al (2001) Classification and diagnostic prediction of cancers using gene expression profiling and artificial neural networks. Nat Med 7:673-679
27. Baer C, Nees M, Breit S et al (2004) Profiling and functional annotation of mRNA gene expression in pediatric rhabdomyosarcoma and Ewing's sarcoma. Int J Cancer 110:687-694
28. Schaaf GJ, Ruijter JM, van Ruissen F et al (2005) Full transcriptome analysis of rhabdomyosarcoma, normal, and fetal skeletal muscle: statistical comparison of multiple SAGE libraries. FASEB J 19:404-406
29. Romualdi C, De Pitta C, Tombolan L et al (2006) Defining the gene expression signature of rhabdomyosarcoma by meta-analysis. BMC Genomics 7:287
30. Athale U, Shurtleff S, Jenkins J et al (2001) Use of reverse transcriptase polymerase chain reaction for diagnosis and staging of alveolar rhabdomyosarcoma, Ewing sarcoma family of tumors, and desmoplastic small round cell tumor. J Pediatr Hematol Oncol 23:99-104
31. Kelly KM, Womer RB, Barr FG (1996) Minimal disease detection in patients with alveolar rhabdomyosarcoma using a reverse transcriptase-polymerase chain reaction method. Cancer 78:1320-1327
32. Frascella E, Rosolen A (1998) Detection of the MyoD1 transcript in rhabdomyosarcoma cell lines and tumor samples by reverse transcription polymerase chain reaction. Am J Pathol 152:577-583
33. Gattenloehner S, Dockhorn-Dworniczak B, Leuschner I et al (1999) A comparison of MyoD1 and fetal acetylcholine receptor expression in childhood tumors and normal tissues: Implications for the molecular diagnosis of minimal disease in rhabdomyosarcomas. J Mol Diagn 1:23-31
34. Gallego S, Llort A, Roma J (2006) Detection of bone marrow micrometastasis and microcirculating disease in rhabdomyosarcoma by a real-time RT-PCR assay. J Cancer Res Clin Oncol 132:356-362
35. Sartori F, Alaggio R, Zanazzo G et al (2006) Results of a prospective minimal disseminated disease study in human rhabdomyosarcoma using three different molecular markers. Cancer 106:1766-1775
36. MacKeigan JP, Murphy LO, Blenis J (2005) Sensitized RNAi screen of human kinases and phosphatases identifies new regulators of apoptosis and chemoresistance. Nat Cell Biol 7:591-600
37. McDowell HP, Meco D, Riccardi A et al (2006) Imatinib mesylate potentiates topotecan antitumor activity in rhabdomyosarcoma preclinical models. Int J Cancer 120:1141-1149
38. Petricoin EF, Espina V, Araujo RP et al (2007) Phosphoprotein pathway mapping: Akt/mammalian target of rapamycin activation is negatively associated with childhood rhabdomyosarcoma survival. Cancer Res 67:3431-3440